Fraxiparine 0.2ml. 0.3ml. 0.4ml. 0.6ml. 0.8ml. 1.0ml Solution for injection.
PDF Leaflet Revision Date: 26 March 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and treatment of DVT and thromboembolic disorders.
Dosage (summary)
0.3 ml subcutaneously before and after surgery; adjust based on body weight.
Onset of Action / Duration
Onset: 3 hours, Duration: 18 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Oral anticoagulants
- Aspirin
- NSAIDs
Contraindications
- Hypersensitivity to nadroparin
- Active bleeding
- Severe renal impairment
Common side effects
- Bleeding
- Thrombocytopenia
- Injection site reactions
Counselling Points
- Monitor for signs of bleeding
- Avoid NSAIDs
- Report any allergic reactions
Serious warnings
- Risk of heparin-induced thrombocytopenia
- Caution with neuraxial anesthesia
Important Disclaimer
The Fraxiparine 0.2ml. 0.3ml. 0.4ml. 0.6ml. 0.8ml. 1.0ml Solution for injection. professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
